CN104667203A - Medicine for treating coronary heart disease - Google Patents
Medicine for treating coronary heart disease Download PDFInfo
- Publication number
- CN104667203A CN104667203A CN201510141104.9A CN201510141104A CN104667203A CN 104667203 A CN104667203 A CN 104667203A CN 201510141104 A CN201510141104 A CN 201510141104A CN 104667203 A CN104667203 A CN 104667203A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- medicine
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 40
- 229940079593 drug Drugs 0.000 title claims description 12
- 210000000582 semen Anatomy 0.000 claims abstract description 20
- 241000218176 Corydalis Species 0.000 claims abstract description 10
- 241000628997 Flos Species 0.000 claims abstract description 10
- 241000005787 Cistanche Species 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 9
- 239000009286 sanguis draxonis Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 34
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 235000014375 Curcuma Nutrition 0.000 abstract 2
- 244000164480 Curcuma aromatica Species 0.000 abstract 2
- 241001121987 Scrophularia ningpoensis Species 0.000 abstract 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241001289295 Asarum sieboldii Species 0.000 abstract 1
- 241000336315 Cistanche salsa Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 240000000513 Santalum album Species 0.000 abstract 1
- 235000008632 Santalum album Nutrition 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 240000001398 Typha domingensis Species 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 8
- 230000004087 circulation Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 206010002383 Angina Pectoris Diseases 0.000 description 6
- 239000012567 medical material Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating a coronary heart disease, and belongs to the technical field of traditional Chinese medicines. The medicine is prepared from the following raw materials in parts by weight: 10-20 parts of angelica sinensis, 5-15 parts of ligusticum wallichii, 6-10 parts of fructus perillae, 20-30 parts of red peony root, 10-20 parts of flos carthami, 15-25 parts of rhizoma corydalis, 10-20 parts of sandalwood, 4-8 parts of curcuma aromatic, 2-6 parts of dragon's blood, 10-20 parts of rhizoma kaempferiae, 6-12 parts of asarum sieboldii, 8-16 parts of peach kernel, 10-20 parts of cattail pollen, 15-25 parts of medicinal cyathula root, 10-16 parts of curcuma zedoary, 20-30 parts of fig, 4-8 parts of semen brassicae, 8-12 parts of scrophularia ningpoensis, 3-8 parts of scrophularia ningpoensis, 10-15 parts of cimicifugae foetidae, 15-25 parts of semen cuscutae, 10-20 parts of radix polygonati officinalis and 20-30 parts of cistanche salsa. The medicine disclosed by the invention is prepared from pure traditional Chinese medicines, and has the characteristics of high curative effect, fast acting, low cost and no side effect, is safe and does not recur after healing.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of coronary heart disease, belong to technical field of Chinese medicines.
Background technology
Coronary heart disease is the heart disease of a kind of myocardial ischemia-anoxemia (angina pectoris) of being caused by coronary artery organic (atherosclerosis or dynamic property vasospasm) stenosis or occlusion or myocardial necrosis (myocardial infarction), also known as ischemic heart desease.Along with the raising of people's living standard, the change of living habit, and the progress faster of aging society, the sickness rate of coronary heart disease increases day by day, affect coronary heart disease occur, development risk factor increasing, seriously jeopardize the health of the mankind.Statistics show, the prevalence of coronary heart disease be generally male higher than women, China in 2011 dies from coronary heart disease number and reaches 3,000,000, and patients with coronary heart disease sum reaches 2.7 hundred million, and wherein the patient of 70 years old accounts for more than 60%, coronary heart disease to the lethality of old people up to 80%.In recent years along with the change of people life style and work rhythm, the sickness rate of coronary heart disease presents the trend of rejuvenation gradually, and in 30-35 year crowd, the sickness rate of patients with coronary heart disease accounts for 5% of whole incidence of coronary heart disease number.Thus the Therapy study of coronary heart disease is seemed particularly urgent.
For the treatment key agents treatment of coronary heart disease and operative treatment two kinds of methods in current doctor trained in Western medicine, but Western medicine side effect is large, and cures the symptoms, not the disease; And operative therapy has a big risk, costly, patient's misery of bearing is large.Coronary heart disease belongs to the category of " thoracic obstruction ", " pained " in the traditional Chinese medical science, uses Coronary Heart Diseases Treated with TCM can not only improve the symptom of patient and can improve the pathology damage of patient to a great extent, shows the advantage that it is unique in coronary heart disease treatment.Market today exists the Chinese medicine for the treatment of coronary heart disease miscellaneous, but their therapeutic effect is general not high, the course for the treatment of is longer, cures the defects such as rear easily recurrence.
Summary of the invention
For problems of the prior art, the invention provides a kind of medicine for the treatment of coronary heart disease.This medicine is formed by pure traditional Chinese medicine, and scientific formulation is reasonable, and have curative effect high, instant effect, do not recur more, cost is low, the feature that safety has no side effect.
The present invention is by the following technical solutions:
A kind of medicine for the treatment of coronary heart disease, it is characterized in that, it is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 10-20 part, Rhizoma Chuanxiong 5-15 part, Fructus Perillae 6-10 part, Radix Paeoniae Rubra 20-30 part, Flos Carthami 10-20 part, Rhizoma Corydalis 15-25 part, Lignum Santali Albi 10-20 part, Radix Curcumae 4-8 part, Sanguis Draxonis 2-6 part, Rhizoma Kaempferiae 10-20 part, Herba Asari 6-12 part, Semen Persicae 8-16 part, Pollen Typhae 10-20 part, Radix Cyathulae 15-25 part, Rhizoma Curcumae 10-16 part, Fructus Fici 20-30 part, Semen Sinapis Albae 4-8 part, Radix Scrophulariae 8-12 part, Radix Arnebiae (Radix Lithospermi) 3-8 part, Rhizoma Cimicifugae 10-15 part, Semen Cuscutae 15-25 part, Rhizoma Polygonati Odorati 10-20 part, Herba Cistanches 20-30 part.
Preferably, the medicine of above-mentioned treatment coronary heart disease is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 15 parts, Rhizoma Chuanxiong 10 parts, Fructus Perillae 8 parts, Radix Paeoniae Rubra 25 parts, 15 parts, Flos Carthami, Rhizoma Corydalis 20 parts, 15 parts, Lignum Santali Albi, Radix Curcumae 6 parts, Sanguis Draxonis 5 parts, Rhizoma Kaempferiae 15 parts, Herba Asari 8 parts, 12 parts, Semen Persicae, Pollen Typhae 15 parts, Radix Cyathulae 20 parts, Rhizoma Curcumae 14 parts, Fructus Fici 25 parts, Semen Sinapis Albae 6 parts, Radix Scrophulariae 10 parts, Radix Arnebiae (Radix Lithospermi) 6 parts, Rhizoma Cimicifugae 12 parts, Semen Cuscutae 20 parts, Rhizoma Polygonati Odorati 15 parts, Herba Cistanches 25 parts.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation, is prepared into any one in tablet, pill, capsule, granule, oral liquid or decoction.
Preferred dosage form of the present invention is capsule.Above medical material is joined by measuring, and pulverized by described medicine as powder crosses 100 mesh sieves afterwards, mixing sterilization incapsulates, and each capsule gets product by 0.4 gram of dress.
Usage of the present invention and consumption: oral, one day 3 times, each 3, within 1 hour after meal, taking, 10 days was 1 course for the treatment of, and general 1 course for the treatment of can take effect, and 3-4 the course for the treatment of can cure, and patient with severe symptoms needs 5-6 the course for the treatment of.
Medicine pharmacological action of the present invention is as follows:
Radix Angelicae Sinensis: sweet, pungent, warm; Return liver, the heart, spleen channel; There is benefiting blood and regulating blood circulation, menstruction regulating and pain relieving, moisturize laxation, anticancer, anti-ageing anti-old, immune effect.Rhizoma Chuanxiong: pungent, temperature; Enter liver, gallbladder meridian; Have activating QI to alleviate the depression, method wind-dryness is wet, effect of promoting blood circulation and stopping pain.Fructus Perillae: pungent, temperature; Return lung meridian; There is sending down the abnormal ascending QI expectorant, relieving cough and asthma, effect of intestine moistening.Radix Paeoniae Rubra: bitter, is slightly cold; Return Liver Channel; There is clearing away heat and cooling blood, effect of blood circulation promoting and blood stasis dispelling.Flos Carthami: pungent, temperature; GUIXIN, Liver Channel; There is promoting blood circulation to restore menstrual flow, effect of eliminating stasis to stop pain.Rhizoma Corydalis: pungent, bitter, temperature; Return liver, spleen channel; Have and invigorate blood circulation, circulation of qi promoting, effect of pain relieving.Lignum Santali Albi: pungent, temperature; Return spleen, stomach, the heart, lung meridian; There is circulation of qi promoting warming middle-JIAO, effect of appetizing pain relieving.Radix Curcumae: pungent, bitter, cold; Return liver, the heart, lung meridian; Have promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, clear away heart-fire removing heat from blood, effect of promoting the function of the gallbladder to alleviate jaundice.Sanguis Draxonis: sweet, salty is flat; GUIXIN, Liver Channel; There is analgesic therapy of invigorating blood circulation, removing stasis to stop bleeding, effect of expelling pus and promoting granulation.Rhizoma Kaempferiae: pungent, temperature; Return spleen, stomach warp; There is warming middle-JIAO for eliminating dampness, effect of promoting the circulation of QI to relieve pain.Herba Asari: pungent, temperature; GUIXIN, lung, kidney channel; There is the cold expelling that induces sweat, wind-expelling pain-stopping, sensible, effect of warming the lung to resolve fluid-retention.Semen Persicae: bitter, sweet, flat; GUIXIN, liver, large intestine channel; There is blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, effect of relieving cough and asthma.Pollen Typhae: sweet, flat; Return liver, pericardium channel; There is hemostasis, blood stasis dispelling, treating stranguria effect.Radix Cyathulae: sweet, micro-hardship, flat; Return liver, kidney channel; There is eliminating blood stasis and inducing menstruation, easing joint movement, effect of inducing diuresis for treating stranguria syndrome.Rhizoma Curcumae: pungent, bitter, temperature; Return liver, spleen channel; There is removing blood stasis circulation of qi promoting, effect of removing food stagnancy pain relieving.Fructus Fici: flat, sweet; Return spleen channel; There is invigorating the spleen and benefiting QI, subduing swelling and detoxicating, nourish effect of intestine moistening.Semen Sinapis Albae: odorless, pungent, peppery; Enter meridian of Hand-TAI YIN; There is warming the lung eliminating phlegm promoting the circulation of QI, effect of resolving mass and removing the obstruction of the collateral pain relieving.Radix Scrophulariae: sweet, bitter, salty, is slightly cold; Return spleen, stomach, kidney channel; Clearing away heat and cooling blood, nourishing YIN to lower pathogenic fire, effect of detoxicating and resolving stagnation of pathogens.Radix Arnebiae (Radix Lithospermi): sweet, salty, cold; GUIXIN, Liver Channel; There is removing heat from blood and promoting blood circulation, effect of removing toxic substances rash.Rhizoma Cimicifugae: pungent, sweet, is slightly cold; Return lung, spleen, large intestine, stomach warp; Deliver rash, heat-clearing and toxic substances removing, effect of ascending up spleen-Qi and Yang.Semen Cuscutae: Xin Gan is flat; Enter liver, kidney channel; Nourishing the liver and kidney, controlling nocturnal emission with astringent drugs reducing urination, antiabortive, effect of improving eyesight antidiarrheal.Rhizoma Polygonati Odorati: sweet, flat; Enter lung, stomach warp; There is nourishing YIN to relieve dryness, effect of promoting the production of body fluid to quench thirst.Herba Cistanches: sweet, salty, warm in nature; Return kidney, large intestine channel; There is kidney-replenishing, benefiting essence-blood, the effect in intestine moistening road.
The invention has the beneficial effects as follows: pharmaceutical formulation of the present invention is scientific and reasonable, its drug effect has synergism, has effect of blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, invigorating the spleen and replenishing QI, warming the kidney to invigorate YANG, effectively can regulate cardiac function.Prove through clinical application for many years, medicine of the present invention is evident in efficacy to various coronary heart disease, and the property of medicine is gentle, and rapidly effective, cure rate is high, does not recur, safe without toxic side effect.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is described in further detail.
Embodiment 1
Treat a medicine for coronary heart disease, it is made up of the crude drug of following weight: Radix Angelicae Sinensis 10g, Rhizoma Chuanxiong 5g, Fructus Perillae 6g, Radix Paeoniae Rubra 20g, Flos Carthami 10g, Rhizoma Corydalis 15g, Lignum Santali Albi 10g, Radix Curcumae 4g, Sanguis Draxonis 2g, Rhizoma Kaempferiae 10g, Herba Asari 6g, Semen Persicae 8g, Pollen Typhae 10g, Radix Cyathulae 15g, Rhizoma Curcumae 10g, Fructus Fici 20g, Semen Sinapis Albae 4g, Radix Scrophulariae 8g, Radix Arnebiae (Radix Lithospermi) 3g, Rhizoma Cimicifugae 10g, Semen Cuscutae 15g, Rhizoma Polygonati Odorati 10g, Herba Cistanches 20g.
Joined by measuring by above-mentioned medical material, pulverized by described medicine as powder crosses 100 mesh sieves afterwards, mixing sterilization incapsulates, and each capsule gets product by 0.4 gram of dress.
Embodiment 2
Treat a medicine for coronary heart disease, it is made up of the crude drug of following weight: Radix Angelicae Sinensis 15g, Rhizoma Chuanxiong 10g, Fructus Perillae 8g, Radix Paeoniae Rubra 25g, Flos Carthami 15g, Rhizoma Corydalis 20g, Lignum Santali Albi 15g, Radix Curcumae 6g, Sanguis Draxonis 5g, Rhizoma Kaempferiae 15g, Herba Asari 8g, Semen Persicae 12g, Pollen Typhae 15g, Radix Cyathulae 20g, Rhizoma Curcumae 14g, Fructus Fici 25g, Semen Sinapis Albae 6g, Radix Scrophulariae 10g, Radix Arnebiae (Radix Lithospermi) 6g, Rhizoma Cimicifugae 12g, Semen Cuscutae 20g, Rhizoma Polygonati Odorati 15g, Herba Cistanches 25g.
Joined by measuring by above-mentioned medical material, pulverized by described medicine as powder crosses 100 mesh sieves afterwards, mixing sterilization incapsulates, and each capsule gets product by 0.4 gram of dress.
Embodiment 3
Treat a medicine for coronary heart disease, it is made up of the crude drug of following weight: Radix Angelicae Sinensis 20g, Rhizoma Chuanxiong 15g, Fructus Perillae 10g, Radix Paeoniae Rubra 30g, Flos Carthami 20g, Rhizoma Corydalis 25g, Lignum Santali Albi 20g, Radix Curcumae 8g, Sanguis Draxonis 6g, Rhizoma Kaempferiae 20g, Herba Asari 12g, Semen Persicae 16g, Pollen Typhae 20g, Radix Cyathulae 25g, Rhizoma Curcumae 16g, Fructus Fici 30g, Semen Sinapis Albae 8g, Radix Scrophulariae 12g, Radix Arnebiae (Radix Lithospermi) 8g, Rhizoma Cimicifugae 15g, Semen Cuscutae 25g, Rhizoma Polygonati Odorati 20g, Herba Cistanches 30g.
Joined by measuring by above-mentioned medical material, pulverized by described medicine as powder crosses 100 mesh sieves afterwards, mixing sterilization incapsulates, and each capsule gets product by 0.4 gram of dress.
Embodiment 4
Treat a medicine for coronary heart disease, it is made up of the crude drug of following weight: Radix Angelicae Sinensis 14g, Rhizoma Chuanxiong 8g, Fructus Perillae 9g, Radix Paeoniae Rubra 28g, Flos Carthami 12g, Rhizoma Corydalis 22g, Lignum Santali Albi 16g, Radix Curcumae 5g, Sanguis Draxonis 5g, Rhizoma Kaempferiae 15g, Herba Asari 10g, Semen Persicae 14g, Pollen Typhae 18g, Radix Cyathulae 18g, Rhizoma Curcumae 14g, Fructus Fici 28g, Semen Sinapis Albae 7g, Radix Scrophulariae 12g, Radix Arnebiae (Radix Lithospermi) 6g, Rhizoma Cimicifugae 14g, Semen Cuscutae 18g, Rhizoma Polygonati Odorati 16g, Herba Cistanches 22g.
Joined by measuring by above-mentioned medical material, pulverized by described medicine as powder crosses 100 mesh sieves afterwards, mixing sterilization incapsulates, and each capsule gets product by 0.4 gram of dress.
Clinical practice example
1. clinical data: patients with coronary heart disease 660 example is accepted in random selecting outpatient service for medical treatment, be divided into two groups of i.e. treatment group and matched groups, clinical data there was no significant difference between two groups, two groups of ages, sex, the course of disease, complication etc. are through statistical procedures, difference there are no significant meaning (P>0. 05), has comparability.
2. diagnostic criteria: according to clinical medical history or electrocardiogram, open in-heart operation under pulsating, the sports load electrocardiogram of angina pectoris, myocardial infarction, Nuclear Cardiac Imaging and coronarography can be made a definite diagnosis.
3. Therapeutic Method: the medicine that treatment group uses the embodiment of the present invention 2 obtained, oral, one day 3 times, each 3, within 1 hour after meal, taking, 10 days was 1 course for the treatment of, and general 1 course for the treatment of can take effect, and 3-4 the course for the treatment of can cure, and patient with severe symptoms needs 5-6 the course for the treatment of.Matched group uses conventional western medicine treatment, as Drug therapys such as sorbide nitrate, beta-blocker, aspirin, verapamil, simvastatins, treats observe the curative effect after 60 days continuously.
4. curative effect determinate standard:
Cure: normal ECG, clinical symptoms all disappears, and follows up a case by regular visits to more than 1 year without recurrence;
Take a turn for the better: electrocardiogram is clearly better, clinical symptoms obviously alleviates or disappears more than half;
Invalid: electrocardiogram is without significant change, and clinical symptoms is without improvement.
5. therapeutic outcome: in table 1.
Table 1 clinical treatment outcome
| Group | Case load | Cure n | Improvement n | Invalid n | Total effective rate % |
| Treatment group | 330 | 286 | 42 | 2 | 99.4% |
| Matched group | 330 | 195 | 55 | 80 | 75.8% |
As can be seen from the above results, the treatment of medicine of the present invention to coronary heart disease has curative effect more better than general Western medicine, and its treatment total effective rate, up to 99.4%, is that one treats coronary heart disease good medicine, brings glad tidings to vast middle-old aged coronary heart disease patient.
Model case
Case 1: money, man, 60 years old, uncomfortable in chest, profuse sweating, Nausea and vomiting and time and with squeezing property pain after breastbone, there is angina pectoris once in a while, be diagnosed as coronary heart disease.After using 1 course for the treatment of of medicine of the embodiment of the present invention 2, clinical symptoms obviously alleviates, and angina pectoris attacks is elongated gradually for interval time, and after 2 courses for the treatment of of rear continuation after treatment, clinical symptoms all disappears, and follows up a case by regular visits to and does not recur for 2 years.
Case 2: what so-and-so, man, 48 years old, chest pain was had a surplus for 3 years repeatedly, can dyspnea when increasing the weight of, and cardiopalmus, companioned with headache is felt sick, and tentative diagnosis is coronary heart disease.After using 3 courses for the treatment of of medicine of the embodiment of the present invention 3, patient clinical symptom all disappears, and follows up a case by regular visits to and does not recur for 1 year.
Case 3: Cai so-and-so, female, 58 years old, paroxysmal chest pain, more than 2 years, was shown effect more than 10 time every day, and with nausea and vomiting, nervous symptom uncomfortable in chest, clinical diagnosis is coronary heart disease.After using 4 courses for the treatment of of medicine of the embodiment of the present invention 1, clinical symptoms all disappears, and follows up a case by regular visits to a year and a half not recur.
Case 4: Guo so-and-so, man, 72 years old, suffer from coronary heart disease to have a surplus for 6 years, often uncomfortable in chest, breathe hard, dizziness, feel sick and with time and angina pectoris sense, angina pectoris attacks was frequent afterwards, constriction uncomfortable in chest is more and more serious, then here treatment, after using 2 courses for the treatment of of medicine of the embodiment of the present invention 4, clinical symptom disappearance is more than half, continue to strengthen patient's recovery from illness after 2 courses for the treatment of of treatment, follow up a case by regular visits to and do not recur for 3 years.
Claims (4)
1. treat the medicine of coronary heart disease for one kind, it is characterized in that, it is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 10-20 part, Rhizoma Chuanxiong 5-15 part, Fructus Perillae 6-10 part, Radix Paeoniae Rubra 20-30 part, Flos Carthami 10-20 part, Rhizoma Corydalis 15-25 part, Lignum Santali Albi 10-20 part, Radix Curcumae 4-8 part, Sanguis Draxonis 2-6 part, Rhizoma Kaempferiae 10-20 part, Herba Asari 6-12 part, Semen Persicae 8-16 part, Pollen Typhae 10-20 part, Radix Cyathulae 15-25 part, Rhizoma Curcumae 10-16 part, Fructus Fici 20-30 part, Semen Sinapis Albae 4-8 part, Radix Scrophulariae 8-12 part, Radix Arnebiae (Radix Lithospermi) 3-8 part, Rhizoma Cimicifugae 10-15 part, Semen Cuscutae 15-25 part, Rhizoma Polygonati Odorati 10-20 part, Herba Cistanches 20-30 part.
2. the medicine for the treatment of coronary heart disease according to claim 1, it is characterized in that, it is made up of the crude drug of following weight portion: Radix Angelicae Sinensis 15 parts, Rhizoma Chuanxiong 10 parts, Fructus Perillae 8 parts, Radix Paeoniae Rubra 25 parts, 15 parts, Flos Carthami, Rhizoma Corydalis 20 parts, 15 parts, Lignum Santali Albi, Radix Curcumae 6 parts, Sanguis Draxonis 5 parts, Rhizoma Kaempferiae 15 parts, Herba Asari 8 parts, 12 parts, Semen Persicae, Pollen Typhae 15 parts, Radix Cyathulae 20 parts, Rhizoma Curcumae 14 parts, Fructus Fici 25 parts, Semen Sinapis Albae 6 parts, Radix Scrophulariae 10 parts, Radix Arnebiae (Radix Lithospermi) 6 parts, Rhizoma Cimicifugae 12 parts, Semen Cuscutae 20 parts, Rhizoma Polygonati Odorati 15 parts, Herba Cistanches 25 parts.
3. the medicine for the treatment of coronary heart disease according to claim 1 and 2, is characterized in that, described pharmaceutical preparation is any one in tablet, pill, capsule, granule or decoction.
4. the medicine for the treatment of coronary heart disease according to claim 3, is characterized in that, described pharmaceutical preparation is capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510141104.9A CN104667203B (en) | 2015-03-30 | 2015-03-30 | A kind of medicine for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510141104.9A CN104667203B (en) | 2015-03-30 | 2015-03-30 | A kind of medicine for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104667203A true CN104667203A (en) | 2015-06-03 |
| CN104667203B CN104667203B (en) | 2018-02-23 |
Family
ID=53303139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510141104.9A Expired - Fee Related CN104667203B (en) | 2015-03-30 | 2015-03-30 | A kind of medicine for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104667203B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108452156A (en) * | 2018-05-02 | 2018-08-28 | 郭书安 | A kind of oral solution for treating coronary heart disease |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101554471A (en) * | 2009-05-21 | 2009-10-14 | 河北金大地房地产开发有限公司 | Traditional Chinese medicine preparation for treating myocardial infarction |
| KR20140142765A (en) * | 2013-06-04 | 2014-12-15 | 한경수 | Food and pharmaceutical composition for preventing or improving thrombotic disease comprising extract of grape leaf as effective component |
-
2015
- 2015-03-30 CN CN201510141104.9A patent/CN104667203B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101554471A (en) * | 2009-05-21 | 2009-10-14 | 河北金大地房地产开发有限公司 | Traditional Chinese medicine preparation for treating myocardial infarction |
| KR20140142765A (en) * | 2013-06-04 | 2014-12-15 | 한경수 | Food and pharmaceutical composition for preventing or improving thrombotic disease comprising extract of grape leaf as effective component |
Non-Patent Citations (2)
| Title |
|---|
| 刘杏鑫: "桃红四物汤加减治疗冠心病68例疗效观察", 《山西中医》 * |
| 孙成宏等: "HPLC法测定桃红丸中羟基红花黄色素A的含量", 《中国药师》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108452156A (en) * | 2018-05-02 | 2018-08-28 | 郭书安 | A kind of oral solution for treating coronary heart disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104667203B (en) | 2018-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20240102982A (en) | Traditional Chinese herbal medicine for the treatment of hives, eczema, allergies/kinetic reactive constitution | |
| CN104784511A (en) | Medicine for treating coronary heart disease | |
| CN115282229B (en) | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type coronary heart disease and preparation method thereof | |
| CN105233188A (en) | Traditional Chinese medicine composition for treating liver cancer and application of traditional Chinese medicine composition | |
| CN101632745A (en) | Traditional Chinese medical compound preparation for treating rheumatism and rheumatoid arthritis | |
| CN105326939A (en) | Traditional Chinese medicine for treating heart and cerebral vusculer diseases | |
| CN104042981A (en) | Medicament for treating postnatal constipation and preparation method thereof | |
| CN104784637B (en) | A kind of Chinese medicine composition of lavipeditum treatment diabete peripheral herve pathology | |
| CN105343688A (en) | Medicine composition for treating myocardial infarction and application thereof | |
| CN104667203A (en) | Medicine for treating coronary heart disease | |
| CN102552520A (en) | Blood circulation-promoting and pain-stopping medicament for treating chest stuffiness and pains and preparation process and application thereof | |
| CN106421639A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN101502583A (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN105126034A (en) | Pharmaceutical preparation for treating coronary heart disease | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN104338052A (en) | Formula of traditional Chinese medicine for treating cerebral thrombosis | |
| CN115252700B (en) | Traditional Chinese medicine composition and medicine for treating cervical tinnitus and preparation method thereof | |
| CN114272329B (en) | Traditional Chinese medicine composition for treating liver and kidney deficiency type cervical spondylosis, preparation and application | |
| CN116135216B (en) | Traditional Chinese medicine composition for treating cervical abscess type lymph node tuberculosis | |
| CN111388564B (en) | Traditional Chinese medicine for treating bradyarrhythmia | |
| CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
| CN101569708B (en) | Medicament for treating ischemic heart disease and preparation method thereof | |
| CN106692821A (en) | Traditional Chinese medicine preparation for treating neurosurgical postoperative headache | |
| CN105169111A (en) | Traditional Chinese medicine composition for treating chronic urticaria and application of traditional Chinese medicine composition | |
| CN102698218A (en) | Traditional Chinese medicine prescription for internal use to treat high blood pressure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Guiqi Inventor before: Jiang Jinli Inventor before: Liu Junfang Inventor before: Xing Yang Inventor before: Xu Qian Inventor before: Zhuang Xuna Inventor before: Wang Yuan |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20180111 Address after: 273500 Zoucheng City Park Road, Jining, Shandong Province, No. 1498, Zoucheng city traditional Chinese medicine hospital, the Department of severe medicine Applicant after: Chen Guiqi Address before: 276600 Tianqiao Road, Junan County, Linyi, Shandong Province, No. 156 Applicant before: Jiang Jinli |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180223 |